Semi-Annual Consolidated Statement Of Cash Flows

SAPPORO CLINICAL LABORATORY INC. - Filing #7325055

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
1,142,998,000 JPY
1,916,053,000 JPY
Interest and dividends received
5,549,000 JPY
5,458,000 JPY
Interest paid
-7,399,000 JPY
-8,091,000 JPY
Income taxes paid
-201,775,000 JPY
-476,074,000 JPY
Net cash provided by (used in) operating activities
1,077,593,000 JPY
1,430,350,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-388,432,000 JPY
-811,059,000 JPY
Proceeds from sale of property, plant and equipment
29,063,000 JPY
395,759,000 JPY
Purchase of investment securities
0 JPY
0 JPY
Other, net
20,581,000 JPY
22,669,000 JPY
Net cash provided by (used in) investing activities
-395,474,000 JPY
-409,028,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-132,017,000 JPY
-133,692,000 JPY
Purchase of treasury shares
JPY
-29,214,000 JPY
Dividends paid
-76,531,000 JPY
-77,048,000 JPY
Net cash provided by (used in) financing activities
-369,961,000 JPY
-347,894,000 JPY
Dividends paid to non-controlling interests
-32,000,000 JPY
JPY
Net increase (decrease) in cash and cash equivalents
312,157,000 JPY
673,427,000 JPY
Cash and cash equivalents
3,966,205,000 JPY
3,654,048,000 JPY
2,980,620,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.